Subjective and objective knowledge and decisional role preferences in cerebrovascular patients compared to controls by Riechel, Christina et al.
© 2016 Riechel et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Patient Preference and Adherence 2016:10 1453–1460
Patient Preference and Adherence Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1453
O r i g i n A l  r e s e A r c h
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/PPA.S98342
subjective and objective knowledge and decisional 









1Department of neurology, 
University Medical center hamburg-
eppendorf, hamburg, germany; 
2nursing research Unit, institute of 
social Medicine and epidemiology, 
University of lübeck, lübeck, 
germany; 3Department of health 
and caring sciences, Faculty of 
health sciences, University of 
Tromsø, Tromsø, norway; 4institute 
of neuroimmunology and Multiple 
sclerosis, University Medical center 
hamburg-eppendorf, hamburg, 
germany; 5Department of neurology, 
Albertinen-Krankenhaus, hamburg, 
germany
*These authors contributed equally 
to this work
Background: Risk knowledge and active role preferences are important for patient involvement 
in treatment decision-making and adherence. Although knowledge about stroke warning signs 
and risk factors has received considerable attention, objective knowledge on secondary preven-
tion and further self-esteem subjective knowledge have rarely been studied. The aim of our 
study was to investigate knowledge and treatment decisional role preferences in cerebrovascular 
patients compared to controls.
Methods: We performed a survey on subjective and objective stroke risk knowledge and 
autonomy preferences in cerebrovascular patients from our stroke outpatient clinic (n=262) 
and from pedestrians on the street taken as controls during a “World Stroke Day” (n=274). The 
questionnaire includes measures for knowledge and decisional role preferences from previously 
published questionnaires and newly developed measures, for example, subjective knowledge, 
revealed on a visual analog scale.
Results: The overall stroke knowledge was low to moderate, with no differences between patients 
and controls. Knowledge about secondary prevention was particularly low. Only 10%–15% of 
participants correctly estimated the stroke absolute risk reduction potential of aspirin. The medical 
data interpretation competence was moderate in both groups. Age and basic mathematical and 
statistical understanding (numeracy) were the only independent predictors of objective stroke 
knowledge, whereas previous stroke had no impact on stroke knowledge. However, patients were 
thought to be better informed than controls. Approximately 60% of both patients and controls 
claimed to prefer a shared decision-making approach in treatment decisions.
Conclusion: The level of stroke risk knowledge in patients with cerebrovascular diseases was 
as low as in randomly selected pedestrians, although patients felt better informed. Both groups 
preferred involvement in treatment decision-making. We conclude that educational concepts 
for increasing awareness of knowledge gaps as well as for stroke risk and for prevention strate-
gies are needed.
Keywords: knowledge, decisional role preferences, cerebrovascular patients, stroke
Introduction
Stroke is the leading cause of acquired permanent disability among adults and 
the second leading cause of death in Western industrialized nations.1 For both 
patients and relatives, stroke significantly affects quality of life.2 Management of 
acute stroke patients has greatly changed during the last decades. Establishment of 
dedicated stroke units has markedly improved acute stroke care and has contributed 
to improved outcomes.3 Although contemporary drugs clearly show significant 
benefits for secondary stroke prevention in randomized controlled trials, adherence 
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and implementation in routine care are still a challenge.4 
It has been postulated that 9% of all cardiovascular events 
in Europe could be attributed to poor adherence to vascular 
medications alone.5 Management of lifestyle and risk factors 
are especially relevant for stroke patients, but show barriers 
in implementation.6
A number of studies have shown that knowledge of stroke 
warning signs and risk factors for general stroke is at best 
low to moderate among healthy individuals, people at risk, 
and after stroke.7,8 Very less work has addressed knowledge 
about secondary stroke prevention, but it has also indicated 
limited secondary prevention knowledge in stroke survivors.9 
These studies focused on objective knowledge based on the 
results of questionnaires. Subjective knowledge of patients, 
meaning a self-rating item of knowledge, has not been 
addressed. In addition, there is only scarce information about 
decisional role preferences in stroke patients,10 mostly from 
trials on atrial fibrillation decision-making.11 Decisional role 
preferences ask for the preferred interaction styles between 
a patient and a physician from a purely autonomous to a 
paternalistic attitude regarding medical decisions. Although 
numerous informative materials for stroke patients already 
exist, patients claim multiple unmet needs, which might 
partially refer to the quality of the available information.12 In 
a recent survey, more than 50% of stroke patients demanded 
more information about their strokes, for example, about 
prevention of recurrence.13 Characteristics and effects of 
interventions to improve medication adherence are uncertain, 
and the full health benefits of medicines are not realized. 
As a consequence, studies aiming at patient knowledge and 
medication adherence are needed.14
It has been postulated that embedding information pro-
vision in a process of shared decision-making is the key to 
better care, better outcomes, and reduced costs.15 Transfer 
of knowledge to facilitate shared decision-making is neces-
sary and might thereby be a major condition of effective 
primary and secondary prevention.16 Thus, evidence-based 
patient information is a prerequisite for informed choice and 
incorporates science and rigor of evidence-based medicine 
with the personal values of patients.17 In neurology, we have 
found a high percentage of autonomous role preferences 
among multiple sclerosis (MS) patients compared to those 
with other diseases.18
This study aimed at assessing stroke risk knowledge in 
patients from a cerebrovascular disease outpatient clinic 
compared to control pedestrians from the street, focusing 
on risk factors and secondary prevention and comparing 
subjective and objective knowledge. Furthermore, we aimed 
at assessing treatment decisional role preferences in patients 
and controls. We assumed that patients with a history of 
cerebrovascular disease would present higher subjective and 
objective risk knowledge.
Methods
We surveyed 262 consecutive patients from the cerebro-
vascular disease outpatient clinic at the Department of 
Neurology, University Medical Centre Hamburg-Eppendorf 
between October 2010 and July 2011. Patients present to 
the cerebrovascular disease outpatient clinic with a cerebro-
vascular risk profile. Most had suffered a previous stroke. 
In parallel, an abbreviated questionnaire was presented 
to 274 randomly selected adult pedestrians, addressed as 
controls, on the street in the pedestrian area of downtown 
Hamburg in October 2010 via an information desk during 
the “World Stroke Day 2010”.
Sample size was determined to be .250 in each group 
to achieve representative results, given that we have no pre-
vious values to calculate the power. Besides demographic 
data, information on stroke knowledge regarding symptoms, 
pathophysiology, treatment, risk factors, and prevention 
were obtained. The questionnaire consisted of the follow-
ing parts:
•	 general questions about stroke symptoms, causes, and 
treatment (four items);
•	 risk factors: diabetes, atrial fibrillation (two items);
•	 secondary prevention: acetylsalicylic acid, blood pressure 
(two items);
•	 medical data interpretation (one item);
•	 self-rated level of stroke knowledge (one item);
•	 autonomy preferences in stroke prevention decision-
making (one item); and
•	 warning signs (nine items).19
One index question (numeracy item) from the Medical 
Data Interpretation Test addressed the capability of comparing 
risk rates on overall mortality of cancer compared to stroke.20 
Subjective stroke knowledge was assessed using a self-rating 
scale of the level of feeling informed about stroke risk. The 
self-rating scale was obtained using a visual analog scale 
from 0 to 10 (0= no subjective knowledge). For analysis, we 
transferred the visual analog scale to a metric count. Auton-
omy preferences were assessed with the Control Preference 
Scale, which asks for five preferred interaction styles from a 
purely autonomous to a paternalistic attitude, with the shared 
decision-making approach as an in-between category.21 In the 
“informed choice” model, patients decide but take physicians’ 
opinions into account, whereas in the “professional as agent” 
model, the physician makes the decision taking the patients 
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Knowledge and decisional preferences in cerebrovascular patients
of a complex interaction, it is the most commonly applied 
and studied tool in the field.21 The categories were briefly 
explained to the patient as a statement on each interaction style 
before they were asked for their preferred decision approach. 
This approach was applied successfully in a previous work.18 
We added nine questions from a recently adapted German 
version of the 16-item Stroke Action Test (STAT) to our 
questionnaire and administered it to a subgroup (96 out of 
296) of the patient cohort.19 This instrument included item 
naming and describing stroke symptoms and has shown 
good reliability in a sample (n=195) of consecutive stroke 
patients in a metropolitan region in Germany (Cronbach’s α 
coefficient .0.9).19
Objective stroke knowledge was defined as the sum of 
correct answers of all questions of knowledge, with the exclu-
sion of the numeracy competence. We used a questionnaire 
format as in the earlier work.18
The final questionnaire tool for patients included 20 questions, 
six general questions about stroke, three in multiple choice, 
nine concerning reaction on warning signs, six relating to deci-
sional role preferences, and one as a visual analog scale.
This study is part of a larger project on the development 
of evidence-based patient information for patients with stroke 
and is a survey study in healthy individuals and in patients 
from a neurovascular unit approved by the Ethics committee 
of the Hamburg Chamber of Physicians and received full sup-
port (Approval: PV 4980). As data analysis was performed 
completely anonymously, and it was considered impractical 
to provide an additional sheet for people interviews on the 
stroke day, we obtained oral informed consent.
statistical analysis
For data analysis, the statistical program SPSS was used 
(version 15.0, SPSS Inc., Chicago, IL, USA). Fisher’s exact 
tests were applied to check variations of autonomy prefer-
ences between the two study cohorts. For analysis of the 
impact of different factors on stroke knowledge, univariate 
and multivariate linear regression analyses were applied. 
Linear regression analysis was conducted for the target 
criterion risk knowledge. Simple linear regressions were 
conducted for each of the six predictors (education, age, sex, 
autonomy preference, cohort, and numeracy competence). 
Corrected r² were calculated, indicating the extent to which 
knowledge could be explained by the particular predictors. 
Finally, a linear regression equation was calculated using all 
six predictors simultaneously. Subjective and objective stroke 
knowledge was compared for the two groups with bivariate 
Pearson correlation coefficient. The influence of age and sex 
was partialized out using stepwise regression analyses.
Results
Two hundred and sixty-two patients and 274 controls were 
included. Patients were older than controls, and there were 
more male patients. There were, however, a few controls 
who had a previous stroke, but the diagnosis of a previous 
stroke was significantly more frequent in the patient cohort 
(Table 1).
Questions concerning symptoms (ie, if impaired vision 
is an acute stroke symptom) and pathophysiology (ie, if 
ischemic stroke is caused by artery occlusion) were correctly 
answered by most of the participants (.90%). Questions 
about primary prevention (eg, treatment of diabetes) and 
secondary prevention (eg, effectiveness of aspirin treatment) 
revealed low levels of knowledge (,50%). Questions about 
risk factors (eg, cardiac arrhythmias) and knowledge about 
pathological blood pressure values revealed moderate lev-
els of knowledge (~50%). The medical data interpretation 
item was answered correctly by only ~40% in both groups. 
Apart from treatment of diabetes, there were no signifi-
cant knowledge differences between patients and controls 
(Table 2).
Study results did not differ when patients with a previous 
stroke in the control cohort were excluded from the analysis. 
No additional significant difference was revealed when only 
patients with previous stroke were compared with controls 
without previous stroke. Only the better knowledge of patients 
concerning the stroke risk in diabetes remained significant.
Regression analysis revealed age and numeracy as inde-
pendent predictors of objective stroke knowledge (Table 3). 
Education, sex, autonomy preference, group, or previous 
stroke had no influence on stroke knowledge.
In the patient subcohort (n=96), when the STAT was 
administered, on average, one-quarter of the patients misclas-
sified the seriousness of possible stroke symptoms (regard-
ing hemiparesis and aphasia, aphasia and paresthesia).19 A 
further 50% of patients misclassified symptoms if they were 
less obvious (eg, loss of vision in one eye) (for detailed data, 
see Table S1).
Patients were thought to be better informed than controls 
(subjective knowledge) even after adjusting for the influence 
of age and sex, but actual (objective) knowledge was low. 
Table 1 Demographic data





Mean age (years) 64 (sD 11.4) 57 (sD 15.7) ,0.001
Female 72 (27.5%) 163 (59.5%) ,0.001
history of stroke 171 (67.6%) 17 (6.2%) ,0.001
Note: aFisher’s exact test.
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In both groups, subjective knowledge was significantly 
higher than objective knowledge (Table 4).
With regard to decisional roles, there was a significant 
difference between patients and controls in the distribution 
of answers (P=0.001). Although in both groups, the majority 
(57% of patients, 64% of controls) claimed a shared decision-
making approach in treatment decisions as preferred, patients 
more frequently favored physician-led decisions (21%) com-
pared to controls (10%) (Figure S1). This difference between 
autonomy preferences of the study groups corresponds with 
an r2 of 0.029 in an ordinal regression analysis. This means 
that only 3% of autonomy preferences are explained by the 
patient’s affiliation to study cohorts (Figure 1). After partial-
izing out the influence of sex and age, only a 1% explained 
variance remained for cohort affiliation.
Discussion
As a major finding in this study, knowledge about stroke 
risk factors and prevention was moderate to low and not 
higher in cerebrovascular patients compared to controls. 
Despite the poor knowledge, patients felt better informed 
than controls.
The lack of stroke knowledge is mirrored in the reac-
tion patterns on warning signs as measured by the STAT 
questionnaire in the patient cohort.19 The necessity to call 
an ambulance even in case of mild stroke symptoms was 
not clear for all the patients in this subgroup. Depending on 
symptoms, ~25%–50% of patients did not consider stroke as a 
possible origin of symptoms. These data are in line with other 
studies showing that less than half of the participants would call 
an ambulance in case of typical stroke symptoms.22 Similarly, 
low knowledge score values were obtained in patients who had 
undergone carotid endarterectomy.23 In particular, it seems that 
increased vascular risk is associated with lower knowledge in 
patients.24,25 This matches our finding of a relevant discrepancy 
between subjective and objective knowledge.
Numerous studies have shown poor knowledge in stroke 
patients and in the public.24,26 For example, only 50% of 
neurological nonstroke patients recognized cerebral artery 
stenosis as an important cause of stroke, whereas 91% identi-
fied hypertension as a vascular risk factor from a provided 
list. However, less than 10% of respondents knew that 
cardiac arrhythmia is a potential cause of stroke.26 Low risk 
knowledge further leads to medication nonadherence and less 
primary care by physicians,27 which points out the need for 
knowledge improvement for stroke prevention.
There was a trend toward more knowledge in patients 
with previous stroke, as study results show a better knowl-
edge regarding the impact of treatment of diabetes on stroke 
risk. But relevant knowledge on secondary prevention is 
missing in patients with previous stroke compared to controls 
without any history of stroke.
Age and numeracy were identified as the only meaningful 
independent predictors of objective stroke knowledge in our 
Table 2 stroke knowledge






impaired vision is an acute 
stroke symptom
220 (84%) 242 (88%) 0.168
ischemic stroke caused 
by artery occlusion
253 (97%) 265 (97%) 1.000
stroke caused by hemorrhage 190 (73%) 203 (74%) 0.697
emergency call in case of mild 
symptoms
208 (79%) 215 (78%) 0.833
Knowledge on stroke risk
Treatment of diabetes 
reduces stroke risk
56 (21%) 94 (34%) 0.001
effectiveness of aspirin 
for prevention
26 (10%) 41 (15%) 0.090
cardiac arrhythmias increase 
stroke risk
112 (43%) 122 (45%) 0.728
Knowledge about 
pathological blood pressure
107 (41%) 99 (36%) 0.287
Medical data interpretation 111 (42%) 117 (43%) 0.938
Notes: Data shown are number of correct responses (%). aFisher’s exact test.
Table 3 Univariate and multivariate regression analysis of 
determinants of stroke knowledge




education 0.007 (0.002) 0.230
Age 0.027 (0.026) ,0.001
sex ,0.001 (0.002) 0.699
Autonomy preference 0.004 (0.001) 0.202
study cohort ,0.001 (0.002) 0.699
numeracy 0.028 (0.027) ,0.001
Multivariate regression
All six predictors 0.037 (0.004) 0.351
Note: aAnalysis of variance.
Table 4 subjective and objective stroke knowledge
Stroke knowledge Patients Controls P-valuea
subjective stroke  
knowledge
6.3±2.5 5.2±2.6 ,0.001
Objective stroke  
knowledge
3.9±1.0 3.8±1.1 0.107
R 0.282 (,0.001a) 0.332 (,0.001a)
Notes: Values are mean ± sD; R= bivariate Pearson correlation coefficient. 
aUnpaired t-test.
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Knowledge and decisional preferences in cerebrovascular patients
study, comparable to previous results.28 This underlines the 
challenge of information provision for aging patients in con-
trast to other patient groups, for example, those with MS.18
Interestingly, patients at the cerebrovascular outpatient 
department, where two out of three had a history of stroke, 
were not better informed than controls. But why did patients 
rate their knowledge higher than controls? Possibly patient 
self-esteem and coping strategies to handle their lives after a 
stroke could explain this discrepancy. In addition, the lack of 
thoroughly processed information in stroke patients might be 
a result of the fact that most receive new medications in an 
emergency setting or shortly thereafter without a thorough 
decision-making process. False estimates about knowledge 
might be a barrier for further information uptake and behavior 
change. Further work is needed to better understand these 
discrepancies.
A recent systematic review stressed substantial unmet 
patient information needs on secondary prevention, including 
lifestyle issues such as diet or exercise.12 This review also 
showed that information to some extent improves patient and 
carer knowledge of stroke, aspects of patient satisfaction, 
and reduces patient depression scores. A recent trial, how-
ever, could not show a consistent effect toward knowledge 
improvement.29 To our knowledge, rigorously developed 
evidence-based patient information has not been studied 
in this field.17 The overestimation of treatment effects of 
acetylsalicylic acid in our survey is another strong indicator 
for the need to improve patient information interventions, 
especially for effective secondary prevention. In addition, our 
screening item on medical data interpretation with only 40% 
correct answers indicates that these interventions have to be 
carefully developed and clinically evaluated to make them 
understandable and helpful for decision-making.30 Recently, 
educational interventions including self-monitoring and 
decision aids for the treatment of atrial fibrillation have been 
systematically reviewed.31 The primary end point time in the 
therapeutic range of an anticoagulant was not significantly 
improved by interventions. Interestingly, decisional conflict 
was enhanced even in educated patients. However, our work 
in MS shows that educated patients make more informed 
choices and might even show improved adherence.32 We 
hypothesize that this approach is also possible in stroke. 
The strong preference of patients and controls to be actively 
involved in medical decision-making emphasizes this goal, 
although patients declared lower levels of autonomy prefer-
ences than controls did.
There were imbalances with regard to sex and age 
between the groups, and we had no information about the 
level of education. However, explained variance by the group 
affiliation was 1% after considering the influence of age and 
sex, which were not equally distributed in the groups, thereby 
indicating that the difference is not clinically meaningful. 
Due to missing data, we do not have much information about 
the risk profile of the cohorts. But, significantly more patients 
had a history of previous stroke (nearly 70%), in contrast to 
controls (~6%). Incomplete data about the risk profile were 
also based on the aim to make a distribution to controls on 
the street feasible. Finally, only a subgroup of the patients 
received the STAT questionnaire, which limits generalization 
of the results for the whole sample.19




































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1






Our data show a low level of risk knowledge among 
cerebrovascular outpatient clinic patients associated with 
a wrongly perceived high subjective knowledge level. 
However, patients claimed the need for involvement in 
decision-making. The lack of knowledge combined with an 
active role preference calls for more systematic approaches 
to enhance knowledge and participation in decision-making 
in cerebrovascular patients. Validated, evidence-based stroke 
patient information might have the potential to close the gap 
between the substantial knowledge about stroke prevention 
derived from controlled trials and the implementation into 
long-term clinical care. However, these information strate-
gies need rigorous evaluation following the framework of 
studying complex interventions. As a consequence, this 
approach might positively impact treatment adherence for 
secondary prevention, which needs further studying.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Heuschmann PU, Busse O, Wagner M, et al. Schlaganfallhäufigkeit 
und Versorgung von Schlaganfallpatienten in Deutschland [Frequency 
and Care of Stroke in Germany]. Aktuel Neurol. 2010;(37):333–340. 
German.
 2. Dennis M, O’Rourke S, Lewis S, Sharpe M, Warlow C. A quantitative 
study of the emotional outcome of people caring for stroke survivors. 
Stroke. 1998;29(9):1867–1872.
 3. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) 
care for stroke. Cochrane Database Syst Rev. 2013;9:CD000197.
 4. Bushnell CD, Zimmer LO, Pan W, et al. Persistence with stroke prevention 
medications 3 months after hospitalization. Arch Neurol. 2010;67(12): 
1456–1463.
 5. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular 
therapy: a meta-analysis of prevalence and clinical consequences. 
Eur Heart J. 2013;34(38):2940–2948.
 6. Lennon O, Galvin R, Smith K, Doody C, Blake C. Lifestyle interventions 
for secondary disease prevention in stroke and transient ischaemic attack: 
a systematic review. Eur J Prev Cardiol. 2014;21(8):1026–1039.
 7. Müller-Nordhorn J, Nolte CH, Rossnagel K, et al. Knowledge about risk 
factors for stroke: a population-based survey with 28,090 participants. 
Stroke. 2006;37(4):946–950.
 8. Jones SP, Jenkinson AJ, Leathley MJ, Watkins CL. Stroke knowledge 
and awareness: an integrative review of the evidence. Age Ageing. 2010; 
39(1):11–22.
 9. Ellis C, Barley J, Grubaugh A. Poststroke knowledge and symptom 
awareness: a global issue for secondary stroke prevention. Cerebrovasc 
Dis. 2013;35(6):572–581.
 10. MacLean S, Mulla S, Akl EA, et al. Patient values and preferences in 
decision making for antithrombotic therapy: a systematic review. Chest. 
2012;141(2 Suppl):e1S–e23S.
 11. Man-Son-Hing M, Gage BF, Montgomery AA, et al. Preference-based 
antithrombotic therapy in atrial fibrillation: implications for clinical 
decision making. Med Decis Making. 2005;25(5):548–559.
 12. Hafsteinsdóttir TB, Vergunst M, Lindeman E, Schuurmans M. Educa-
tional needs of patients with a stroke and their caregivers: a systematic 
review of the literature. Patient Educ Couns. 2011;85(1):14–25.
 13. McKevitt C, Fudge N, Redfern J, et al. Self-reported long-term needs 
after stroke. Stroke. 2011;42(5):1398–1403.
 14. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhanc-
ing medication adherence. Cochrane Database Syst Rev. 2014;11: 
CD000011.
 15. Oshima Lee E, Emanuel EJ. Shared decision making to improve care 
and reduce costs. N Engl J Med. 2013;368(1):6–8.
 16. Lenz M, Buhse S, Kasper J, Kupfer R, Richter T, Mühlhauser I. Deci-
sion aids for patients. Dtsch Arztebl Int. 2012;109(22–23):401–408.
 17. Bunge M, Mühlhauser I, Steckelberg A. What constitutes evidence-
based patient information? Overview of discussed criteria. Patient Educ 
Couns. 2010;78(3):316–328.
 18. Heesen C, Kasper J, Sega J, Köpke S, Mühlhauser I. Decisional role 
preferences, risk knowledge and information interests in patients with 
multiple sclerosis. Mult Scler. 2004;10(6):643–650.
 19. Roebers S, Razum O, Kutschmann M, Wagner M. Entwicklung und 
Evaluation einer deutschen Version des Fragebogens Stroke Action Test 
(STAT) zur Ermittlung der Kenntnisse über das richtige Verhalten bei 
einzelnen Schlaganfallsymptomen [Development and evaluation of a 
German version of the Questionnaire Stroke Action Test (STAT) to 
assess knowledge of the correct response to individual stroke symp-
toms]. Aktuel Neurol. 2008;35(7):334–339. German.
 20. Schwartz LM, Woloshin S, Welch HG. Can patients interpret health 
information? An assessment of the medical data interpretation test. 
Med Decis Making. 2005;25(3):290–300.
 21. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and 
decisional preferences in women with breast cancer. JAMA. 1997; 
277(18):1485–1492.
 22. Hickey A, Holly D, McGee H, Conroy R, Shelley E. Knowledge of 
stroke risk factors and warning signs in Ireland: development and 
application of the Stroke Awareness Questionnaire (SAQ). Int J Stroke. 
2012;7(4):298–306.
 23. Maruthappu M, Shalhoub J, Thapar A, Jayasooriya G, Franklin IJ, 
Davies AH. The patients’ perspective of carotid endarterectomy. Vasc 
Endovascular Surg. 2010;44(7):529–534.
 24. Lambert C, Vinson S, Shofer F, Brice J. The relationship between knowl-
edge and risk for heart attack and stroke. J Stroke Cerebrovasc Dis. 
2013;22(7):996–1001.
 25. Carroll C, Hobart J, Fox C, Teare L, Gibson J. Stroke in Devon: knowl-
edge was good, but action was poor. J Neurol Neurosurg Psychiatry. 
2004;75(4):567–571.
 26. Wiszniewska M, Głuszkiewicz M, Kobayashi A, et al. Knowledge of 
risk factors and stroke symptoms among nonstroke patients. Eur Neurol. 
2012;67(4):220–225.
 27. Koenig KL, Whyte EM, Munin MC, et al. Stroke-related knowledge and 
health behaviors among poststroke patients in inpatient rehabilitation. 
Arch Phys Med Rehabil. 2007;88(9):1214–1216.
 28. Schneider AT, Pancioli AM, Khoury JC, et al. Trends in community 
knowledge of the warning signs and risk factors for stroke. JAMA. 
2003;289(3):343–346.
 29. Eames S, Hoffmann T, Worrall L, Read S, Wong A. Randomised 
controlled trial of an education and support package for stroke patients 
and their carers. BMJ Open. 2013;3(5): pii: e002538.
 30. Heesen C, Kleiter I, Nguyen F, et al. Risk perception in natalizumab-
treated multiple sclerosis patients and their neurologists. Mult Scler. 
2010;16(12):1507–1512.
 31. Gattellari M, Leung DY, Ukoumunne OC, Zwar N, Grimshaw J, 
Worthington JM. Study protocol: the DESPATCH study: delivering 
stroke prevention for patients with atrial fibrillation – a cluster randomised 
controlled trial in primary healthcare. Implement Sci. 2011;6:48.
 32. Köpke S, Kern S, Ziemssen T, et al. Evidence-based patient information 
programme in early multiple sclerosis: a randomised controlled trial. 




































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1




Knowledge and decisional preferences in cerebrovascular patients
Supplementary materials
Table S1 reaction on warning signs (patient subgroup n=96)
Assumed action Call an ambulance Visit general practitioner Notify relatives Wait
symptom
hemiparesis and aphasia 86 (91%) 2 (2%) 7 (7%) 0
Aphasia 22 (69%) 5 (16%) 1 (3%) 4 (12%)
Paresthesia 63 (66%) 22 (23%) 6 (6%) 5 (5%)
Dizziness, nausea, vomiting 67 (70%) 25 (26%) 3 (3%) 1 (1%)
loss of vision in one eye 45 (47%) 43 (45%) 3 (3%) 5 (5%)
severe headache 62 (66%) 28 (30%) 2 (2%) 2 (2%)
Known headache 6 (6%) 57 (60%) 5 (5%) 28 (29%)
chest pain 82 (86%) 10 (11%) 2 (2%) 1 (1%)
Abdominal pain and nausea 16 (17%) 67 (72%) 2 (2%) 8 (9%)
Notes: 96% completed the questionnaire. n = number of responses (%).
General questions about stroke
In the following, we want to ask you some general questions about stroke. In case you are not sure about the answer, try to reply as best 
as possible.
(Please choose only one answer per row)
Correct False Do not know
An acute stroke can present by sudden visual loss. [ ] [ ] [ ]
In case of mild stroke symptoms (for example, sensibility loss of one 
arm or leg), it is adequate to present to the general practitioner next day.
[ ] [ ] [ ]
A stroke can be caused by a cerebral arterial vessel occlusion. [ ] [ ] [ ]
A stroke can be caused by a cerebral bleeding. [ ] [ ] [ ]
Antidiabetic medications lower blood glucose level and decrease the 
long-term stroke risk.
[ ] [ ] [ ]
Cardiac arrhythmias are an important cause of stroke. [ ] [ ] [ ]
Stroke risk knowledge









Arterial hypertension increases the risk of stroke. Treatment with 
antihypertensive medication reduces the risk of stroke. Which is the 
lowest blood pressure value (mmHg) already considered hypertensive?
[ ] [ ] [ ] [ ]
.90 ~60 ~30 .10
100 patient take aspirin after suffering a stroke. In how many cases, 
a secondary prevention of stroke can be reached?
[ ] [ ] [ ] [ ]
Cancer Stroke Both risk
Mrs Meyer is informed by her physician that her risk dying of cancer is 
1 to 296. Her risk dying after stroke is 1 to 407. Which risk is higher?
[ ] [ ] [ ]
Decision-making
There are different kinds of decision making regarding the prevention of stroke.
(Please choose which form you would prefer:)
I want to decide for myself, which kind of treatment I receive. [ ]
I want to decide for myself, which kind of treatment I receive, after I took the opinion of my physician into account. [ ]
I want to decide together with my physician, which kind of treatment would be the best for me. [ ]
I want my physician to decide, which kind of treatment would be the best for me, but taking my opinion into account. [ ]
I want my physician to decide, which kind of treatment would be the best for me. [ ]
How high would you self-estimate your knowledge about stroke prevention?
(Please mark the line)
I have no  
knowledge 1 2 3 4 5 6 7 8 9 10
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